Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC for peritoneal carcinomatosis
2016-003394-18Phase 2Completed
- Sponsor
- Michael Bau Mortensen
- Start
- Sep 2016
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, doxorubicin and oxaliplatin in peritoneal carcinomatosis (PC), sponsored by Michael Bau Mortensen. Started Sep 2016; status: completed.
02
Drugs
cisplatindoxorubicinoxaliplatin
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on 2016-003394-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003394-18.